Sertić, Z.; Lucijanić, M.; Bašić-Kinda, S.; Serventi Seiwerth, R.; Periša, V.; Sertić, D.; Coha, B.; Pulanić, D.; Perić, Z.; Desnica, L.;
et al. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines 2022, 10, 2892.
https://doi.org/10.3390/biomedicines10112892
AMA Style
Sertić Z, Lucijanić M, Bašić-Kinda S, Serventi Seiwerth R, Periša V, Sertić D, Coha B, Pulanić D, Perić Z, Desnica L,
et al. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines. 2022; 10(11):2892.
https://doi.org/10.3390/biomedicines10112892
Chicago/Turabian Style
Sertić, Zrinka, Marko Lucijanić, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, Božena Coha, Dražen Pulanić, Zinaida Perić, Lana Desnica,
and et al. 2022. "Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem" Biomedicines 10, no. 11: 2892.
https://doi.org/10.3390/biomedicines10112892
APA Style
Sertić, Z., Lucijanić, M., Bašić-Kinda, S., Serventi Seiwerth, R., Periša, V., Sertić, D., Coha, B., Pulanić, D., Perić, Z., Desnica, L., Mikulić, M., Vodanović, M., Radman-Livaja, I., Šegulja, D., Rogić, D., Valković, T., Aurer, I., & Duraković, N.
(2022). Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem. Biomedicines, 10(11), 2892.
https://doi.org/10.3390/biomedicines10112892
